A lot of people notice either an increase or a decrease in libido during their SARM cycles. In this article, we will go over just that. We will explain why an increase or a decrease in libido happens during SARM cycles.
For the majority, SARMs increase libido in the first half of the cycle and decrease it towards the end. After that, the libido slowly stabilizes and returns to normal once your natural Testosterone production recovers back to normal.
We will explain this in more detail.
Let’s dive right in.
SARMs increase libido
According to this 2007 study, SARMs actually result in an increase in libido. At least in the majority of the cycle.
Quote from the study:
“It is recognized that androgen administration helps to improve libido and mood in both men and women.”
Basically, SARMs increase libido in the first half of the cycle because of all the hormonal changes.
You might be asking yourself, what about the other half of the cycle? Let’s go over that.
SARMs decrease libido
As we said, SARMs will increase libido in the first half of the cycle because of the hormonal changes.
In the second half of the cycle, however, libido will most likely decrease because of the suppression.
All SARMs are suppressive to some extent and because of that, our natural production of Testosterone will be lower towards the end of the cycle. Because of that, libido decreases towards the end of the cycle.
You don’t need to worry though. Our bodies naturally recover from suppression after the cycle is over. Usually, that takes about 2-4 weeks. So after about 4 weeks, libido returns back to normal, as it was before the SARM cycle.
Conclusion
In conclusion, SARMs can increase and decrease libido. Usually, SARMs increase libido in the first half of the cycle. After that, libido slowly decreases towards the end of the cycle.
Libido stabilizes and returns to normal after you are finished with your SARM cycle and your natural production of Testosterone comes back to normal.
It’s worth noting that compounds such as Cardarine or Stenabolic aren’t SARMs so this doesn’t apply to them.
